The Data and Safety Monitoring Committee ( DSMC ) recommended stopping the trial on Jan @ , @ ( last patient visit July , @ ) , after an interim analysis , and suggested a change in primary outcome from the difference in proportions of patients with incident progression between groups to time to visual field deterioration within @ months .